Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia

por Robinson, Delbert G., Suett, Mark, Wilhelm, Amanda, Chaijale, Nayla, Franzenburg, Kelli R., Gandhi, Sanjay, Cloud, Blaine, Mychaskiw, Marko
Publicado 2023

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study

por Buse, Dawn C., Gandhi, Sanjay K., Cohen, Joshua M., Ramirez-Campos, Verena, Cloud, Blaine, Yang, Ronghua, Cowan, Robert P.
Publicado 2020